CAM
TARO

Claret Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Claret Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,119
Closed -$213K – 153
2022
Q3 		$213K Sell
7,119
-107
-1% -$3.69K 0.05% 124
2022
Q2 		$261K Sell
7,226
-53
-0.7% -$2.02K 0.06% 117
2022
Q1 		$315K Sell
7,279
-417
-5% -$19.5K 0.06% 115
2021
Q4 		$386K Sell
7,696
-1,640
-18% -$91.9K 0.07% 113
2021
Q3 		$594K Sell
9,336
-2,035
-18% -$141K 0.1% 95
2021
Q2 		$818K Sell
11,371
-3,937
-26% -$289K 0.13% 82
2021
Q1 		$1.13M Sell
15,308
-1,307
-8% -$99.2K 0.21% 67
2020
Q4 		$1.22M Sell
16,615
-21,767
-57% -$1.4M 0.24% 60
2020
Q3 		$2.1M Sell
38,382
-19,355
-34% -$1.2M 0.47% 44
2020
Q2 		$3.84M Sell
57,737
-17,354
-23% -$1.16M 0.91% 29
2020
Q1 		$4.6M Sell
75,091
-7,342
-9% -$544K 1.3% 23
2019
Q4 		$7.25M Sell
82,433
-4,041
-5% -$341K 1.39% 21
2019
Q3 		$6.52M Sell
86,474
-6,041
-7% -$490K 1.34% 21
2019
Q2 		$7.9M Sell
92,515
-1,516
-2% -$150K 1.64% 16
2019
Q1 		$10.2M Sell
94,031
-287
-0.3% -$28.6K 2.02% 13
2018
Q4 		$7.98M Buy
94,318
+57
+0.1% +$5.5K 1.77% 14
2018
Q3 		$9.27M Buy
94,261
+20
+0% +$2.16K 1.79% 16
2018
Q2 		$10.9M Buy
94,241
+1,749
+2% +$192K 2.22% 12
2018
Q1 		$9.13M Sell
92,492
-1,300
-1% -$132K 2.08% 14
2017
Q4 		$9.82M Buy
+93,792
New +$10.3M 2.14% 14

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Claret Asset Management's TARO Position: Q4 2022 in Review

Claret Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2022, closing a stake of 7,119 shares — an estimated $213K sold.

Claret Asset Management first reported a position in TARO in Q4 2017 and held it in 20 quarters. The position peaked at $10.9M in Q2 2018. 62 funds tracked by Wall St. Rank hold TARO as of Q4 2022.

  • Claret Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2022 after selling out during the quarter.
  • Claret Asset Management sold 7,119 Taro Pharmaceutical Industries Ltd. shares in Q4 2022, an estimated $213K.
  • Claret Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2017 and held it in 20 quarters.
  • Claret Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $10.9M in Q2 2018.
  • 62 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2022.

Based on Claret Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.